MedPath

A Randomized controlled study on Brihat HaridraKhanda And Haridrakhanda in the management of Chronic Urticaria (Sheet Pitta,Udarda,Kotha)

Not yet recruiting
Conditions
Urticaria, unspecified,
Registration Number
CTRI/2019/10/021642
Lead Sponsor
Parul Institute of Ayurved
Brief Summary

This Study is a Randomized, Parallel Group, Active Controlled trial to compare the efficacy of Brihat Haridrakhand in the Dose of 4 Gram TID with the vehicle of Ushnodak for the duration of 30 Days in 15 Patients of Chronic Urticaria and Haridrakhand in the Dose of 4 Gram TID with the vehicle of Ushnodak for the duration of 30 Days in 15 Patients of Chronic Urticaria will be conducted in India.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Diagnosed case of Chronic Urticaria patients will be selected.

Exclusion Criteria
  • Major systemic illness like CRF, DM, Thyroid related disease.
  • History of Anaphylaxis to medicine and food.
  • Patients suffering from other skin diseases such as eczema, Psoriasis or other skin disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All the signs and symptoms of chronic urticaria will be assigned score depending upon their severity to assess the effect of the drugs at the time of Before and After treatment.30 Days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Parul Institute of Ayurved and Hospital

🇮🇳

Vadodara, GUJARAT, India

Parul Institute of Ayurved and Hospital
🇮🇳Vadodara, GUJARAT, India
Dr Naishadh Bharatkumar Sharma
Principal investigator
7874016363
drnaishadhbharatsharma@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.